sefulness of Beta-D Glucan (BDG) test in the treatment of fungal diseases in intensive care setup
Not Applicable
- Conditions
- Health Condition 1: B49- Unspecified mycosis
- Registration Number
- CTRI/2023/07/055921
- Lead Sponsor
- Apollo Hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Above 18 years of age who are admitted in critical acre unit for whom BDG test ahs been ordered
Exclusion Criteria
No specific exclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method